Abbott India (Obimet and Thyrocab) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Abbott India (Obimet and Thyrocab) General Information

Description

Two prescription drug brands comprising of 14 product line extensions. The portfolio includes Obimet and Thyrocab drugs that help manage diabetes and hyperthyroidism.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 16th Floor, Godrej BKC, Plot - C, G Block
  • Bandra-Kurla Complex, Bandra (East)
  • Mumbai, Maharashtra 400051
  • India
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • 16th Floor, Godrej BKC, Plot - C, G Block
  • Bandra-Kurla Complex, Bandra (East)
  • Mumbai, Maharashtra 400051
  • India

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abbott India (Obimet and Thyrocab) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Abbott India (Obimet and Thyrocab)‘s full profile, request access.

Request a free trial

Abbott India (Obimet and Thyrocab) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Abbott India (Obimet and Thyrocab)‘s full profile, request access.

Request a free trial

Abbott India (Obimet and Thyrocab) FAQs

  • Where is Abbott India (Obimet and Thyrocab) headquartered?

    Abbott India (Obimet and Thyrocab) is headquartered in Mumbai, India.

  • What industry is Abbott India (Obimet and Thyrocab) in?

    Abbott India (Obimet and Thyrocab)’s primary industry is Buildings and Property.

  • Is Abbott India (Obimet and Thyrocab) a private or public company?

    Abbott India (Obimet and Thyrocab) is a Private company.

  • What is Abbott India (Obimet and Thyrocab)’s current revenue?

    The current revenue for Abbott India (Obimet and Thyrocab) is .

  • Who are Abbott India (Obimet and Thyrocab)’s investors?

    Abbott India has invested in Abbott India (Obimet and Thyrocab).

  • When was Abbott India (Obimet and Thyrocab) acquired?

    Abbott India (Obimet and Thyrocab) was acquired on 02-Apr-2018.

  • Who acquired Abbott India (Obimet and Thyrocab)?

    Abbott India (Obimet and Thyrocab) was acquired by Corona Remedies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process